Clinical trial Recruiting at 4 sites Observational

Peripheral nerve decompression plus nerve stimulation for painful diabetic neuropathy

Official title: Study on the Safety and Therapeutic Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy

Run by Qilu Hospital of Shandong University · NCT07911410 · Data updated 2026-11-12

This study looks at whether combining nerve decompression with nerve stimulation can help reduce pain in people with painful diabetic neuropathy.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorQilu Hospital of Shandong University
Academic / other
Locations4 sites (Jinan, Shandong and 3 other locations)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedApril 30, 2027
Study endsMay 31, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07911410 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with diagnosed painful diabetic peripheral neuropathy who had a first-time lower-extremity peripheral nerve decompression plus peripheral nerve stimulation and have complete electronic medical records.

Probably not a fit

Patients with non-painful or predominantly non-neuropathic symptoms, those with prior decompression surgery, or those with significant comorbidities may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational analysis gathers patients with diabetic peripheral neuropathy who underwent lower-extremity peripheral nerve decompression combined with peripheral nerve stimulation. It involves multi-center data from four Chinese hospitals collected between January 2025 and May 2026. The aim is to document safety and potential pain relief, as well as the impact on numbness and function, in a real-world setting. The study builds on the idea that nerve compression contributes to symptoms and explores whether a combined surgical and neuromodulation approach offers benefits beyond standard pharmacologic therapy. No interventional randomization is described in this observational design.

Why it matters

Potential benefit: If successful, patients may experience reduced pain and improved nerve-related symptoms with a procedure that targets both compression and nerve signaling.

How similar studies have gone: Prior evidence suggests nerve decompression and neuromodulation can relieve neuropathic pain in selected patients, but this exact combination in PDPN is less established and largely relies on observational data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients diagnosed with DPN who underwent lower extremity peripheral nerve decompression combined with PNS lead implantation in the Department of Neurosurgery of four hospitals (Qilu Hospital of Shandong University, Tangdu Hospital of Air Force Military Medical University, Army Medical Center of Army Medical University (Daping Hospital), and the First People's Hospital of Hangzhou Affiliated to Westlake University) between January 1, 2025 and May 31, 2026.
2. Patients with a confirmed diagnosis of diabetic peripheral neuropathy with pain as the predominant symptom.
3. Patients receiving lower extremity peripheral nerve decompression combined with PNS lead implantation for the first time.
4. Patients with complete electronic medical record data.

Exclusion Criteria:

1. Patients who have previously undergone lower extremity peripheral nerve decompression surgery.
2. Patients with severe comorbidities, including severe cardiac disease, hepatic or renal insufficiency, and immune system deficiency.
3. Patients with substantial missing data.

Where it's running

  • Qilu hospital
    Jinan, Shandong, China
    Recruiting
  • Department of Neurosurgery, Tang-Du Hospital
    Xi’an, Shanxi, China
    Recruiting
  • Department of Neurosurgery, Hangzhou First People's Hospital
    Hangzhou, Zhejiang, China
    Recruiting
  • Department of Neurosurgery,Daping Hospital of Army Medical University
    Chongqing, China
    Recruiting

Study contacts

  • Principal investigator: Ning Yang, doctor — Department of Neurosurgery, Qilu Hospital of Shandong University
  • Study coordinator: Ning Yang, doctor
  • Email: yangning@sdu.edu.cn
  • Phone: +86 18560088290

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.